Navigation path

Pharmaceuticals - Community Register

  

List of nationally authorised medicinal products for human use

Nimesulide containing medicinal products for systemic use

Product name: Nimesulide containing medicinal products for systemic use
Also marketed in the EU under the name(s): Alencast, Algimesil, Algolider, Algosulid, Algover, AllGone, Ameolin, Amocetin, Antalgo, Aponil, Apronil, Areuma, Aulin, Auromelid, Biolin, Bioxidol, Chemisulide, Cliovyl, Coxtral, Delfos, Dimesul, Discorid, Dolostop, Domes, Donulide, Efridol, Elinap, Elinap, Enetra, Eudolene, Fansulide, Fladalgin, Flogostop, Flolid, Guaxan, Isodol, Kartal, Lalide, Ledoren, Lemesil, Lemesilin, Melicat, Melimont, Mesilex, Mesulid, Mesulid Fast, Mesupon, MIN-A-PON, Mosuolit, Multiformil, Myxina, Naofid, Nerelid, Nexen, Nidol, Nimed, Nimed, Nimedex, Nimelid, Nimelide, Nimesil, Nimesul, Nimesulene, Nimesulida, Nimesulide, Nimm, NIMS, Nise, Noalgos, Omnibus, Oronime, Oxetian, Pantames, Remov, Ristolzit, Ritamine, Rolaket, Solving, Speclid, Sulidamor, Tranzicalm, Ventor, Volonten, Xilox
Active substance: Nimesulide
Indication: Treatment of acute pain. Primary dysmenorrhoea.
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/01/2012 Referral EMEA/H/A-31/1261 (2011)10130 of 20/01/2012